Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of ONO-7269 Intravenous Infusion in Healthy Japanese Subjects
jRCT2080224112Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ONO-7269 (3 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Safety and tolerability of ONO-7269, Pharmacokinetics of ONO-7269 and 1 more. Started Oct 2018; status: completed.
02
Drugs
ONO-7269
Beyond the preview
Go deeper on jRCT2080224112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224112.